| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |